The Sr. Director, GRA, Product Communications, is responsible for demonstrating regulatory leadership and influence in facilitating effective partnerships with assigned US Business Unit working along with other cross-functional leaders and alliance partners to consistently and efficiently develop and deliver accurate, balanced, substantiated product and disease information which enables informed decision making by our customers (patient, provider and payer). To effectively partner and support the needs of the US Business Unit, the Sr. Director will lead a team of regulatory personnel, providing administrative oversight and direct supervision. The Sr. Director must also develop mutually productive relationships with the FDA Office of Prescription Drug Promotion (OPDP), Lilly components and alliance partners in support of marketed product activities. Additionally, the Sr. Director leads regulatory personnel during the internal strategy discussions, preparation and implementation of interactions with OPDP.